All Pathways
OtolaryngologyEmergency

Acute Epiglottitis Management

Acute Epiglottitis Management: Suspected acute epiglottitis (supraglottitis) → Do not upset the patient: no throat examination → Adult (16 years or olde...

Pathway Overview

19 steps

Algorithm Steps

19 total

  1. 01Start

    Suspected acute epiglottitis (supraglottitis)

    Severe sore throat or pain on swallowing out of proportion to the throat findings, muffled voice, drooling, fever. May have stridor or distress. Child: often not fully Hib-vaccinated or immunocompromised; toxic, anxious, sits upright, little cough.

  2. 02Warning

    Do not upset the patient: no throat examination

    Agitation, lying flat or sedation can cause complete airway obstruction. Let the patient sit in the position they choose (a child on the parent's lap). Call the most senior airway clinician now.

    • No tongue depressor and no oropharyngeal examination
    • Do not lie the patient flat and do not sedate
    • Never leave the patient alone; keep difficult-airway and front-of-neck access equipment ready
  3. 03Decision

    Adult (16 years or older)?

    Adult: assess airway risk, then work up. Child under 16 years: secure the airway in theatre before any procedure.

  4. If Yes
    1. 04Decision

      Adult: airway at risk?

      Yes if any of: stridor at rest, respiratory distress, sitting forward or tripod, cannot lie flat, cannot swallow saliva, falling SpO2, cyanosis, altered mental state, or rapid progression over hours.

    2. If Yes
      1. 05Warning

        Adult, airway at risk: anaesthetist and ENT now

        Adult with airway at risk: move with the airway team to theatre (or resuscitation bay if no time). About 1 in 25 intubation attempts fail: have front-of-neck access ready before any attempt. Do not send to radiology.

        • Keep upright; no sedation
        • While waiting: oxygen; nebulised adrenaline 1 mg/mL, 5 mL undiluted (1:1000) may give temporary relief but must not delay the airway
        • Complete obstruction or arrest: one laryngoscopy attempt, then immediate front-of-neck access (scalpel-bougie-tube)
      2. 06Action

        Adult: secure the airway in theatre (double set-up)

        Adult: most experienced anaesthetist and ENT surgeon scrubbed, neck marked, tracheostomy set open. Choose by severity and skills: awake fibreoptic or video intubation, awake tracheostomy, or inhalational induction keeping spontaneous breathing.

        • Keep spontaneous breathing until the airway is secured
        • Tube smaller than predicted; cuffed
        • Failed intubation: surgical airway (front-of-neck access), not repeated attempts
        • Once the airway is secure: blood cultures, then antibiotics
      3. 07Action

        IV ceftriaxone after blood cultures

        Adult: ceftriaxone 2 g IV once daily. Child (from 4 weeks): ceftriaxone 50 mg/kg (max 2 g) IV once daily, after the airway is secure. Septic shock or meningitis: higher dose per local guideline.

        • Neonate under 4 weeks: use cefotaxime, not ceftriaxone (jaundice, calcium-containing IV fluids)
        • Neutropenic: give the local neutropenic fever regimen within 1 hour instead, and seek infectious diseases advice
        • Immediate severe beta-lactam allergy or other immunocompromise: seek infectious diseases advice now; do not delay antibiotics
        • MRSA risk: add vancomycin (dose and levels per local guideline)
        • Step down to oral antibiotics when able to swallow; course length per local antimicrobial guideline
      4. 08Action

        Consider dexamethasone (evidence limited)

        May reduce swelling; observational data link steroids to shorter ICU and hospital stay. Never a substitute for securing the airway. Child: dexamethasone 0.6 mg/kg (max 16 mg) IV or IM after the airway is secure. Adult: dose per local protocol.

        • Diabetes: monitor blood glucose
      5. 09Action

        Hib confirmed: notify public health; clearance antibiotics

        Hib is notifiable: tell the public health unit. Droplet precautions until 48 hours after a clearance antibiotic. Index case not treated with ceftriaxone or cefotaxime: rifampicin before discharge. Household contacts: only if the household has a vulnerable contact, then treat all household contacts.

        • Vulnerable contact: infant under 7 months; child 7 months to 5 years not fully Hib-vaccinated; immunocompromised or asplenic person
        • Rifampicin 20 mg/kg (max 600 mg) orally once daily for 4 days (child or adult); neonate under 1 month: 10 mg/kg once daily for 4 days
        • Rifampicin interacts with hormonal contraception, oral anticoagulants, antiretrovirals, tacrolimus and ciclosporin: check first; advise non-hormonal contraception
        • Pregnant or cannot take rifampicin: ceftriaxone for 2 days (12 years or older: 1 g IM or IV daily; under 12 years: 50 mg/kg, max 1 g, daily)
        • No benefit more than 30 days after contact; childcare contacts per public health unit
        • Unimmunised child under 5 years: Hib catch-up vaccination after discharge. Hib disease after full vaccination: refer for immune work-up
      6. 10Decision

        Airway secured (intubated or tracheostomy)?

        All patients: ICU or high-dependency bed with an airway team available at once. Tracheostomy: ENT and ICU plan weaning and decannulation when the swelling settles.

      7. If Yes
        1. 11Decision

          Intubated: ready for extubation?

          Intubated: extubate only when fever and swelling have settled and a cuff leak is present. Usually a second look at the larynx under sedation or anaesthesia first; extubate where re-intubation and surgical airway are available.

        2. If Yes
          1. 12Outcome

            Extubated and recovering

            Extubated: observe in ICU or HDU. Complete antibiotics. Discharge when swallowing and stable. ENT follow-up. Check vaccinations are up to date.

          If No
          1. 13Outcome

            Not ready: stay intubated, reassess daily

            Not ready for extubation: continue ICU care and antibiotics; reassess daily. Look for abscess or other complications if not improving.

        If No
        1. 14Outcome

          Not intubated: monitored bed, serial review

          Not intubated: most adults (about 85 to 90%) need no airway intervention. Continuous SpO2, repeat ENT nasendoscopy, airway team available. New stridor, distress or rapid progression: anaesthetist and ENT, theatre. Step down, then discharge when swallowing, afebrile and improving; complete antibiotics; ENT follow-up.

      If No
      1. 15Action

        Adult, airway not at risk: careful work-up

        Adult with airway not at risk: keep upright in a resuscitation-capable area with continuous SpO2. Tell anaesthesia and ENT now. IV access, FBC, blood cultures; start IV antibiotics without waiting for imaging.

        • Stridor, distress or rapid progression at any time: treat as airway at risk (anaesthetist and ENT, theatre)
        • No ENT on site: discuss with ENT and arrange transfer with an airway-skilled escort
      2. 16Action

        Adult: flexible nasendoscopy by ENT

        Adult, airway not at risk: flexible nasendoscopy confirms the diagnosis and shows the degree of swelling. Do it sitting up, where the airway can be secured at once. Marked swelling, a narrowed airway or an abscess: anaesthetist and ENT decide together now whether to secure the airway in theatre.

      3. 17Action

        Stable adult, only if needed: lateral neck X-ray or CT

        Stable adult only, and only if nasendoscopy is not available, the diagnosis is unclear, or an abscess is suspected. A portable lateral neck X-ray may show the thumb sign but a normal film does not exclude epiglottitis. CT needs the patient to lie flat: only if the airway is secure or clearly stable, with an airway-skilled escort.

        • Never send a patient with airway risk to radiology
        • Lateral X-ray misses about 1 in 5 adult cases (one cohort study)
        • CT shows abscess and extent of swelling
      4. Path rejoins step 07Shared downstream outcome
    If No
    1. 18Warning

      Child: airway first, no procedures

      Child with suspected epiglottitis: keep calm with the parent. Defer cannula, bloods and X-ray until the airway is secure. Senior anaesthetist and ENT now; move together to theatre. No anaesthetist or ENT on site: call the paediatric retrieval service now. Oxygen as tolerated; it does not relieve obstruction.

      • Complete obstruction or arrest: 2-person bag-mask ventilation with 100% oxygen, and intubation by the most skilled clinician (smaller tube)
      • Cannot intubate, cannot oxygenate: emergency front-of-neck access per the local paediatric CICO guideline
      • Life-threatening obstruction while waiting: nebulised adrenaline 1 mg/mL, 5 mL undiluted (1:1000) for temporary relief
    2. 19Action

      Child: gas induction in theatre, ENT ready

      Child: inhalational (gas) induction by a senior anaesthetist, keeping spontaneous breathing. ENT present and ready for a surgical airway.

      • Tube 0.5 to 1 size smaller than usual for age; cuffed
      • Once the airway is secure: IV access, blood cultures, then antibiotics
    3. Path rejoins step 07Shared downstream outcome

Guideline Source

Booth AWG et al. Airway management of adult epiglottitis: systematic review and meta-analysis. BJA Open 2024;9:100250 (adults); RCH Melbourne CPG Acute upper airway obstruction 2021 (children); CDNA SoNG Invasive Hib infection v2 2025 (contacts)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • No society guideline exists for epiglottitis: adult airway steps come from a 2024 systematic review, child steps from the RCH upper airway obstruction guideline.
  • Antibiotic course length and the adult dexamethasone dose are not given: follow the local antimicrobial guideline (in Australia, Therapeutic Guidelines: Antibiotic).
  • Hib contact prophylaxis follows Australian CDNA guidance; criteria differ in other countries.
  • Non-infective supraglottitis (thermal, caustic, immune checkpoint inhibitor) and epiglottitis in neutropenic patients need specialist advice.

Contraindicated Populations

neonates_under_4_weeks_ceftriaxonepregnancy_rifampicin

Applicable Regions

AUUSEU

AU: Hib is notifiable; contact clearance follows the CDNA Series of National Guidelines (2025). Ampicillin-sulbactam is not on the ARTG. Paediatric retrieval: state retrieval service.

EU: Hib contact prophylaxis criteria differ between countries: follow the national public health agency.

US: Hib contact prophylaxis criteria differ from Australia: follow the local public health department.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Acute Epiglottitis Management?

The Acute Epiglottitis Management is a emergency clinical algorithm for Otolaryngology. It provides a structured decision tree to guide clinical decision-making, based on Booth AWG et al. Airway management of adult epiglottitis: systematic review and meta-analysis. BJA Open 2024;9:100250 (adults); RCH Melbourne CPG Acute upper airway obstruction 2021 (children); CDNA SoNG Invasive Hib infection v2 2025 (contacts).

What guideline is the Acute Epiglottitis Management based on?

This algorithm is based on Booth AWG et al. Airway management of adult epiglottitis: systematic review and meta-analysis. BJA Open 2024;9:100250 (adults); RCH Melbourne CPG Acute upper airway obstruction 2021 (children); CDNA SoNG Invasive Hib infection v2 2025 (contacts) (DOI: 10.1016/j.bjao.2023.100250).

What are the limitations of the Acute Epiglottitis Management?

Known limitations include: No society guideline exists for epiglottitis: adult airway steps come from a 2024 systematic review, child steps from the RCH upper airway obstruction guideline.; Antibiotic course length and the adult dexamethasone dose are not given: follow the local antimicrobial guideline (in Australia, Therapeutic Guidelines: Antibiotic).; Hib contact prophylaxis follows Australian CDNA guidance; criteria differ in other countries.; Non-infective supraglottitis (thermal, caustic, immune checkpoint inhibitor) and epiglottitis in neutropenic patients need specialist advice.. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Epiglottitis Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free